HANGZHOU, China, Dec. 15, 2023 /PRNewswire/ — Recently, the general adviser to the Prime Minister of Thailand and the Minister of Foreign Trade of Thailand, Narumon Pinyosinwat, held talks with a Chinese business delegation in Bangkok to discuss how to help Thai products better enter the Chinese market. At the invitation of the Thai government, Anit Osathanugrah, head of a well-known Thai consortium, head of Thaitrade, Kevin Chen’s team of the Chinese state-owned enterprise delegation, Gary Yu Qing, partner of Xingyun Group/CEO of LinkieBuy, and representatives of WeChat Pay, etc. Attended the conference.

The conference focused on the theme of "From Zero to Hero", discussing ways to help Thai companies build a marketing and sales system for their products from scratch and increase their sales in the Chinese market through large-scale online e-commerce platforms in China.

Thai representatives expressed their wish to create a project/course to provide business training for Thai companies that want to enter the Chinese market, help them better understand the trends of the Chinese market, and design products better suiting the Chinese market, and provide them with legal knowledge so as to ensure efficient export of their products.

The Chinese side will make use of major Chinese online platforms such as WeChat and mini programs to discuss curriculum development with Thailand, including cooperation with the Ministry of Commerce of Thailand to further develop the online market through Thaitrade.

Thai representatives attached great importance to the talks and highly praised Chinese enterprises, and the Chinese delegation expressed its full confidence in the cooperation. Gary Yu Qing, CEO of LinkieBuy, presented a tea set symbolizing the Chinese culture to the general adviser of the Prime Minister of Thailand, Ms. Narumon Pinyosinwat, enhancing the friendship between China and Thailand during the trade talks.

Previously, LinkieBuy, one of the representatives of Chinese enterprises, had already signed a strategic cooperation agreement with BIGC, a Thai company. LinkieBuy has rich experience in helping Thai companies enter the Chinese market, and has already helped BiGC operate in the Chinese market and has accumulated hundreds of thousands of mini program users. After this meeting and negotiation, LinkieBuy will work with the state-owned enterprise delegation to create a powerful B2B2C lineup covering the entire industrial chain and opening up a wider channel for Thai products to enter the Chinese market.

LinkieBuy is subsidiary of Xingyun Group, a Top 500 Enterprise in China. It is China’s leading digital operation solution service provider integrating online and offline scenarios. It provides full-link digital solutions from online SaaS mall construction, payment and system API connection, e-commerce agency operation, brand communication, marketing, customer acquisition, CRM customer management, private domain operation and purchase, to offline warehousing, logistics supply chain, flow to stores, and store member management. It helps brands and retailers comprehensively upgrade and improve their operation efficiency and volume of trade.

At the end of the conference, Ms. Narumon said, "We hope this cooperation with large Chinese companies can benefit Thai entrepreneurs, help increase the volume of exports of Thai products, and boost the Thai economy."

CONTACT: Jason Liu, +8619357593669, [email protected] 

Source : LinkieBuy, a Subsidiary of Xingyun Group, was Invited to Participate in Trade Talks Organized by the Thai Government Aiming to Help Thai Products Enter the Chinese Market

>

This content was prepared by our news partner, Cision PR Newswire. The opinions and the content published on this page are the author’s own and do not necessarily reflect the views of Siam News Network

HONG KONG, Dec. 15, 2023 /PRNewswire/ — Heidrick & Struggles (Nasdaq: HSII), a premier provider of global leadership advisory and on-demand talent solutions, added a principal to its Executive Search business in Asia Pacific in November 2023. 

Diana Low joined Heidrick & Struggles’ Singapore office as a member of the global Consumer Markets Practice. With 20 years of experience in executive search and leadership advisory, she has extensive experience working with clients on C-level and functional positions. Previously, she worked at two other global search firms.  

"With her rich industry experience, Diana offers valued insights into building capabilities for our consumer-facing clients, including e-commerce, media and entertainment, and leisure and hospitality," said Stephen McAlinden, regional leader for Asia Pacific and the Middle East.  

About Heidrick & Struggles
Heidrick & Struggles (Nasdaq: HSII) is a premier provider of global leadership advisory and on-demand talent solutions, serving the senior-level talent and consulting needs of the world’s top organizations. In our role as trusted leadership advisors, we partner with our clients to develop future-ready leaders and organizations, bringing together our services and offerings in executive search, diversity and inclusion, leadership assessment and development, organization and team acceleration, culture shaping and on-demand, independent talent solutions. Heidrick & Struggles pioneered the profession of executive search more than 65 years ago. Today, the firm provides integrated talent and human capital solutions to help our clients change the world, one leadership team at a time.® www.heidrick.com

Heidrick & Struggles Media Contact:
Lillian Lee
+852 2103 9389
[email protected]

Source : Heidrick & Struggles Welcomes New Principal in Asia Pacific

>

This content was prepared by our news partner, Cision PR Newswire. The opinions and the content published on this page are the author’s own and do not necessarily reflect the views of Siam News Network

ILiAD to be Licensed and Deployed at Livent’s Resource in Argentina

SAN DIEGO, Dec. 14, 2023 /PRNewswire/ — Today, ILiAD Technologies, LLC and Livent Corporation (NYSE:LTHM) announced an agreement whereby Livent has acquired a minority stake in the parent company of ILiAD Technologies. ILiAD Technologies’ parent company is a subsidiary of EnergySource Minerals (ESM), a leading developer of lithium projects in the Salton Sea Known Geothermal Resource Area in California. ILiAD Technologies will seek to commercialize and continue to develop the ILiAD (Integrated Lithium Adsorption Desorption) technology platform.

ILiAD uses an innovative direct lithium extraction (DLE) technology that was developed over seven years of research and pilot testing by ESM. This highly efficient and flexible extraction technology can be used to recover high-purity lithium chloride from lithium-laden brine resources around the world, including brine from salars, produced water, geothermal brine operations, and other lithium resources.

In connection with its investment in ILiAD Technologies, Livent will have the right to license ILiAD technology for anticipated deployment at its lithium brine resource in Argentina (Salar del Hombre Muerto), and is evaluating opportunities for future production use across its portfolio. The ILiAD solution is complementary to Livent’s proprietary process technologies and readily fits into the company’s existing plant designs and flowsheet. Additionally, ILiAD offers the potential for significant improvements in Livent’s energy usage and carbon footprint as well as continued improvements in water use. Commercial utilization of ILiAD at Livent could begin as early as 2025.

"Livent is the world’s foremost practitioner and largest user of DLE-based production processes, and we are thrilled that they have recognized the advantages that ILiAD brings to the future of DLE. Our technology enhances the lithium extraction process with a fraction of the physical footprint of traditional operations, significantly less water use and lower carbon emissions than many other DLE solutions, and no consumption of reagents," said Samuel Moore, Chief Executive Officer of ILiAD Technologies. "This partnership represents a major step in our mission to deploy ILiAD for environmentally responsible lithium production across the world," added Moore.

"We are excited to partner with ILiAD Technologies as we continue to invest in processes and technologies which advance our strategy of producing high-quality lithium chemicals efficiently and sustainably," said Paul Graves, Livent’s President and CEO. "The ILiAD platform is a next generation, best-in-class technology that we expect will enhance and complement Livent’s existing proprietary processes, helping us build upon our decades-long record of successfully using DLE-based production processes at commercial scale." 

Evercore acted as a financial advisor to ESM and ILiAD Technologies.

ABOUT ILiAD TECHNOLOGIES

ESM ILiAD is a private direct lithium extraction (DLE) technology company affiliated with EnergySource Minerals. The company licenses the ILiAD Technology Platform, a proprietary breakthrough technology which combines a superior lithium selective adsorbent with continuous countercurrent bed processing to deliver a unique, patented solution capable of concentrating and treating a vast range of lithium laden brines under a wide variety of conditions. The technology is poised to be deployed globally to sustainably produce lithium to meet the immense and growing demand for its use in the manufacturing of Electric Vehicle batteries.

ESM shareholders are TechMet Limited, a leading technology metals investment company with a portfolio of assets that responsibly produce, process, and recycle the metals that are critical to the global energy transition and the electric vehicle revolution; SLB New Energy, a global technology company driving energy innovation to accelerate decarbonization; Catalyst Geothermal LLC and LiNergy LLC, both U.S. based private investors in new energy technologies; and Mercury NZ Ltd., a New Zealand electricity generation and multi-product utility retailer.

For more information, visit: https://www.iliadtech.com/.

ABOUT LIVENT

For nearly eight decades, Livent has partnered with its customers to safely and sustainably use lithium to power the world. Livent is one of only a small number of companies with the capability, reputation, and know-how to produce high-quality finished lithium compounds that are helping meet the growing demand for lithium. The Company has one of the broadest product portfolios in the industry, powering demand for green energy, modern mobility, the mobile economy, and specialized innovations, including light alloys and lubricants. Livent has a combined workforce of approximately 1,350 full-time, part-time, temporary, and contract employees and operates manufacturing sites in the United States, England, China and Argentina. For more information, visit Livent.com.

Media Contacts:

ILiAD Technologies: John Horstman | [email protected] | +1 (224) 430-1910

Livent Media: Juan Carlos Cruz | [email protected] | +1 (215) 299-6725

Livent Investor Relations: Daniel Rosen | [email protected] | +1 (215) 299-6208

Safe Harbor Statement under the Private Securities Litigation Reform Act of 1995: Certain statements in this news release are forward-looking statements. In some cases, we have identified forward-looking statements by such words or phrases as "will likely result," "is confident that," "expect," "expects," "should," "could," "may," "will continue to," "believe," "believes," "anticipates," "predicts," "forecasts," "estimates," "projects," "potential," "intends" or similar expressions identifying "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995, including the negative of those words and phrases. Such forward-looking statements are based on our current views and assumptions regarding future events, future business conditions and the outlook for the Company based on currently available information. There are important factors that could cause Livent’s actual results, level of activity, performance or achievements to differ materially from the results, level of activity, performance or achievements expressed or implied by the forward-looking statements, including the factors described under the caption entitled "Risk Factors" in Livent’s 2022 Form 10-K filed with the Securities and Exchange Commission ("SEC") on February 24, 2023, as well as other SEC filings and public communications. Although Livent believes the expectations reflected in the forward-looking statements are reasonable, Livent cannot guarantee future results, level of activity, performance or achievements. Moreover, neither Livent nor any other person assumes responsibility for the accuracy and completeness of any of these forward-looking statements. Livent is under no duty to update any of these forward-looking statements after the date of this news release to conform its prior statements to actual results or revised expectations.

Logo – https://mma.prnasia.com/media2/2301701/4458141/Livent_H_RGB_Logo.jpg?p=medium600
Logo – https://mma.prnasia.com/media2/2301702/4458142/ILiAD_Color_Logo_Logo.jpg?p=medium600

Source : LIVENT INVESTS IN ILiAD TECHNOLOGIES TO STRENGTHEN LEADERSHIP IN DIRECT LITHIUM EXTRACTION PRODUCTION PROCESSES

>

This content was prepared by our news partner, Cision PR Newswire. The opinions and the content published on this page are the author’s own and do not necessarily reflect the views of Siam News Network

Nona Biosciences will receive a total of up to $53 Million in upfront and near-term payments, with the potential for milestones of up to $1.05 billion plus royalties. Pfizer partnership expands Nona’s global network of collaborations, reinforcing its commitment to providing cutting-edge technology innovation to novel therapeutics development.

CAMBRIDGE, Mass., Dec. 15, 2023 /PRNewswire/ —  Nona Biosciences, a global biotechnology company providing a total solution from "Idea to IND" (I to ITM), ranging from target validation and antibody discovery through preclinical research, announced today that it has entered into an exclusive license agreement with Pfizer Inc. for the global clinical development and commercialization of Nona Biosciences’ MSLN-targeted antibody-drug conjugate (ADC), HBM9033.

Under the terms of the agreement, Nona Biosciences will receive a total of up to $53 million in upfront and near-term payments, with the potential for additional payments of up to $1.05 billion upon achieving certain development and commercial milestones. Nona Biosciences is also eligible to receive tiered royalties on net sales ranging from high single digits to high teens.

"We are delighted to collaborate with Pfizer, a company that is committed to developing high-impact medicines for people living with cancer," said Jingsong Wang, M.D., Ph.D., Chairman of Nona Biosciences. "This agreement represents a significant milestone in the advancement of our proprietary Harbour Mice® platform and the ADC ecosystem, affirming Nona’s robust capabilities and expertise in antibody discovery and development. This partnership with Pfizer further enhances Nona’s global network of collaborations through innovative models, thereby amplifying the scientific and commercial value of our technology platforms."

About HBM9033

HBM9033 is an ADC drug that specifically targets human MSLN, a tumor-associated antigen (TAA) upregulated in various solid tumors. The fully human monoclonal antibody (mAb) in HBM9033 is derived from the Harbour Mice® platform and possesses well-tuned properties, exhibiting reduced binding to shedding MSLN (sMSLN) while maintaining strong binding and internalization to membrane-bound MSLN. The unique design of the mAb ensures superior potency and safety in various preclinical tumor models with differing MSLN expression levels, positioning HBM9033 as a potential globally best-in-class therapeutic option.

About Nona Biosciences

Nona Biosciences (a wholly-owned subsidiary of HBM Holdings Limited, HKEX: 02142) is a global biotechnology company committed to cutting-edge technology innovation and provides a total solution from "Idea to IND" (I to ITM), ranging from target validation and antibody discovery through preclinical research. The integrated antibody discovery services range from antigen preparation, animal immunization, highly robust antibody screening, to antibody lead generation and engineering, developability assessment and pharmacological evaluation, leveraging advantages of Harbour Mice® technology and the experienced therapeutic antibody discovery team.

Harbour Mice® generate fully human monoclonal antibodies in a traditional two heavy and two light chain (H2L2) format, and a heavy chain only (HCAb) format. Integrating Harbour Mice® with highly robust antibody screening platforms, Nona Biosciences is focused on driving global inventions of transformative next-generation drugs. For more information, please visit www.nonabio.com and follow us on LinkedIn.

Source : Nona Biosciences Enters into a Global License Agreement with Pfizer for HBM9033, an MSLN-Targeted Antibody-Drug Conjugate (ADC)

>

This content was prepared by our news partner, Cision PR Newswire. The opinions and the content published on this page are the author’s own and do not necessarily reflect the views of Siam News Network

First Mandopop Artist As Global Ambassador For Dior Fashion

Popstar’s new single release on Dec. 22

Sets Record Of The Most Audience In Bangkok Stadium For Mandopop Artist

TAIPEI, Dec. 15, 2023 /PRNewswire/ — The King of Mandopop, Jay Chou, successfully ended his Carnival world concert tour at the Rajamangala National Stadium in Bangkok, Thailand this past weekend. Notably, a series of stunning stage outfits caught much attention from the audience, adding an extra spotlight to the show. These outfits were designed by Kim Jones, the creative director of DIOR, exclusively for Jay’s stage performance. Today, Dior has officially announced Jay Chou as its exceptional new global ambassador, "The multi-talented international icon, singer, songwriter, director and actor Jay Chou is now global ambassador for Dior fashion and Kim Jones collections." Not only is this the first time Jay becomes ambassador for a fashion designer brand, but also it’s the first time Dior presents a Mandopop artist as ambassador for its brand worldwide. The superstar will release a new single on Dec. 22, just before Christmas.

In making the announcement, DIOR stated, "As our new global ambassador, Jay embodies the spirit and singularity of Dior style, a modernity with a timeless signature. Driven by audacity and creativity, this alliance celebrates more than ever the special ties uniting Dior and culture in all its forms."

Jay, represented by Dominant Culture Ltd, in response to his latest appointment, said, "I am thrilled to join Dior as a global ambassador and am very grateful for Dior’s custom-designed stage ensembles for the concerts in Bangkok. We have been working together on the stage outfits and performing in Dior, which truly makes the stage experience incredibly special. I am looking forward to our journey ahead with Dior.

After two decades, Jay is finally back in Thailand for his concert tour, stunning his fans with spectacular show and of course eye-catching customized DIOR outfits designed by the brand’s creative director Kim Jones. Over 70,000 fans came to Jay’s two concerts in Bangkok, setting records as the first Mandopop superstar to achieve the most audience at the Rajamangala National Stadium.

Last year, the megastar’s music album release, "Greatest Works of Art," marked a historic moment, making him the first Mandarin artist to break into the top 10 of the IFPI 2022 Global Artist Chart and top the Global Album Sales Chart. He also made outstanding achievements in crossing into the films and arts, with his previous debut in the Hollywood movies "The Green Hornet" and "Now You See Me II", and his collaboration with Christie’s and Sotheby’s. As he always says life has no limits, this time Jay continues to spread his international influence with DIOR in a fashionable way.  

https://www.instagram.com/jaychou/  

Source : DIOR ANNOUNCES JAY CHOU AS NEW GLOBAL AMBASSADOR

>

This content was prepared by our news partner, Cision PR Newswire. The opinions and the content published on this page are the author’s own and do not necessarily reflect the views of Siam News Network

SYDNEY, Dec. 15, 2023 /PRNewswire/ — Intuitive investment and trading platform moomoo was named Online Broker Rising Star Gold Winner at Money Magazine’s recent 2024 Best of the Best awards.

Moomoo received the Online Broker Rising Star Gold Winner award at Money Magazine’s Best of the Best 2024 ceremoney on December 6th, 2023

The award recognises moomoo as a leading trading platform in providing Australian investors with access to global markets and a host of innovative trading tools to support their trading and investing journeys.

Matt Wilson, Vice-President and Chief Market Strategist at Moomoo AU, commented, "We are thrilled to have been recognised as the Online Broker Rising Star Gold Winner by the Money Magazine’s 2024 Best of the Best awards."

"Moomoo is committed to creating the most technically advanced trading platform in the market, driven by customer demands and feedback," said Mr Wilson.

"In the past six months, moomoo has launched or enhanced more than 2,500 features, a feat few companies can compete with due to the size and strength of our IT R&D team.

"We have 1,600 staff dedicated to research and development; an advanced customer service team that is yet to be matched in our industry."

The Best of the Best awards have been reviewed and assessed by Rainmaker Information, publisher of Money, for more than 20 years.

Rainmaker’s review is not only based on the affordability of the broker’s trading fees but also on the performance and range of trading features on the platform.

Moomoo offers 38 drawing tools and more than 100 technical indicators to Australians at no cost, making the platform stand out among Australian investors. 

"Trading is a serious endeavour, but it’s also rewarding and fulfilling. We aim to create enjoyable and accessible trading experiences to empower our investors," said Mr Wilson.

"Our AI-powered trading features allow investors to not only track the growth of their investment portfolio but also identify related stocks, trending markets and the investment portfolio of high-performing investors."  

"We are grateful for the trust our clients place in us and will continue to strive for excellence in our product and services. We look forward to building on this success in 2024 and beyond." 

For more information regarding moomoo, please visit moomoo’s official website at www.moomoo.com/au or feel free to email: [email protected].

About moomoo 

Based in Sydney, NSW, Australia, Futu Securities (Australia) Ltd is an indirect and wholly owned subsidiary of Futu Holdings Ltd, an advanced technology company transforming the investing experience by offering a fully digitized brokerage and wealth management platform. Futu Holdings Ltd was ranked second in Fortune magazine’s Fortune 100 list in 2022.

Moomoo’s mission is to provide all investors with an intuitive and powerful investing platform, built with proprietary technology. We leverage our deep technological R&D capabilities and future-focused operating model to constantly improve our clients’ experience and drive industry-wide innovation.

Securities services available on the moomoo App are offered by but not limited to the following brokerage firms: Futu Securities (Australia) Ltd regulated by the Australian Securities and Investments Commission (ASIC); Moomoo Financial Inc. regulated by the U.S. Securities and Exchange Commission (SEC), Moomoo Financial Singapore Pte. Ltd. regulated by the Monetary Authority of Singapore (MAS), and Futu Securities International (Hong Kong) Ltd. regulated by the Securities and Futures Commission of Hong Kong (SFC).

Moomoo Financial Inc. is a member of the U.S. Securities Investor Protection Corporation (SIPC). The SIPC provides limited protection over an investor’s U.S. securities and cash when a member brokerage firm is to be liquidated. SIPC does not protect against losses due to market volatility.

Source : Trading Platform Moomoo Named Online Broker Rising Star Gold Winner by Money Magazine

>

This content was prepared by our news partner, Cision PR Newswire. The opinions and the content published on this page are the author’s own and do not necessarily reflect the views of Siam News Network

NEWARK, Calif., Dec. 15, 2023 /PRNewswire/ — Today, TYAN®, an industry-leading server platform design manufacturer and a MiTAC Computing Technology Corporation subsidiary, announced its new server motherboard powered by the latest Intel® Xeon® E-2400 processor (codenamed Raptor Lake-E). TYAN’s new solution is built to provide improved performance, better PCIe support, and faster memory speeds for cost-effective servers with essential performance to support entry-level bare metal services in datacenters and on-premise servers with 24/7 reliability to support business-critical services and customer data needs in small businesses.

New Intel Xeon E-2400 Processors: Essential Performance, Expandability and Reliability for Entry-level Servers

The new Intel Xeon E-2400 processors provide enhanced performance over the prior generation, frequencies up to 5.6 GHz with Intel® Turbo Boost Max Technology 3.0 and up to 128GB DDR5 memory with speeds up to 4800 MT/s and ECC support. It also delivers greater I/O expandability with up to 16 lanes of PCIe 5.0 from CPU, up to 24 lanes of PCIe 4.0 from CPU and PCH for typical server requirements. In addition, by employing Intel® Server Platform Services (Intel® SPS) 6 firmware with Intel® Node Manager support, E-2400 processors provide modern manageability and security as baseline for entry server applications.

TYAN Tempest CX S5573: A Cost-Effective On-Premise Solution

Featuring the Intel Xeon E-2400 processors, the new TYAN Tempest CX S5573 is a motherboard designed for cloud and on-premise computing. "Our customers could enjoy excellent performance while being competitive by taking advantage of Intel processor-embedded DDR5 and PCIe 5.0 technologies", said Eric Kuo, Vice President of Server Infrastructure Business Unit, MiTAC Computing Technology Corporation.

TYAN Tempest CX S5573, a server motherboard with the Micro-ATX form factor,  supports single Intel Xeon E-2400 processor, four DDR5-4800 DIMM slots, three PCIe slots, eight SATA 6G ports, two NVMe M.2 slots, and dual 25GbE LAN ports on a tailored mezzanine. Also, thanks to the standard form factor, Tempest CX S5573 can be easily deployed in a rackmount or pedestal chassis for many kinds of applications, including on-premise servers in small businesses and front-end servers in datacenters.  

About TYAN

TYAN, as a leading server brand of MiTAC Computing Technology Corporation under the MiTAC Holdings Corp. (TSE:3706), designs, manufactures and markets advanced x86 and x86-64 server/workstation board technology, platforms and server solution products. Its products are sold to OEMs, VARs, System Integrators and Resellers worldwide for a wide range of applications. TYAN enables its customers to be technology leaders by providing scalable, highly-integrated, and reliable products for a wide range of applications such as server appliances and solutions for HPC, hyper-scale/data center, server storage, AI and security appliance markets. For more information, please visit TYAN’s website at http://www.tyan.com or MiTAC Computing Technology Corporation website at http://www.mitacmct.com

Intel, the Intel logo, Xeon and combinations thereof are trademarks of Intel Corporation

Source : TYAN's New Server Motherboard Supports the Latest Intel® Xeon® E-2400 Processors

>

This content was prepared by our news partner, Cision PR Newswire. The opinions and the content published on this page are the author’s own and do not necessarily reflect the views of Siam News Network

NavaX will revolutionize the end-to-end Research and Development processes with the latest advanced technologies

BOSTON, Dec. 15, 2023 /PRNewswire/ — ArisGlobal, a market leader in Life Sciences technology and the creator of LifeSphere®, has today launched LifeSphere NavaX, a cutting-edge cognitive computing engine to expedite R&D IT Digitization by leveraging advanced technologies including Large Language Models (LLM) and Generative AI (Gen AI).

LifeSphere is the industry’s leading R&D compliance platform. In 2018, the company introduced LifeSphere MultiVigilance (LSMV), a platform for individual case safety report (ICSR) intake. LSMV was powered by LifeSphere Nava (v1) – at introduction, LifeSphere Nava offered the latest robotic process automation and cognitive computing technologies, including natural language processing (NLP) and machine learning (ML), to transform pharmacovigilance (PV) activities.

Today, LifeSphere NavaX includes next-generation technologies that will bring comprehensive efficiency gains across the end-to-end PV and regulatory processes. Organizations leveraging LifeSphere NavaX will benefit from the latest developments from ArisGlobal, including:

Proactive Signal Detection (with the use of Real-World Data), Generative AI (Gen AI), and Large Language Models (LLM) features and functionality

Half (49%) of all Life Sciences organizations have cited a desire to deploy Gen AI in the next 12 months, in a survey conducted for the Gartner 2024 CIO Agenda, with 15% pointing to deployment within 12-24 months; only 8% having deployed the technology already. The growing appetite for smart process automation reflects the soaring pressure on Life Sciences companies and their PV and Regulatory operations to be more agile and efficient, uphold the highest standards of patient safety while improving quality and compliance.

Aman Wasan, CEO of ArisGlobal, said: "Our vision is to transform the R&D IT ecosystem with advanced technology. NavaX will help global pharmaceutical, biotech, and health authorities achieve greater value leveraging cutting-edge technology. With more than 30 years of experience in the Life Sciences industry,  ArisGlobal team will work closely with each customer to unlock exceptional benefits with NavaX."

Ann-Marie Orange, CIO & Global Head of R&D at ArisGlobal said, "Companies are facing monumental challenges including increasing case volume, balancing the need to elevate drug safety and efficacy while containing rising R&D costs, responding to regulatory complexity, and a growing pressure to harness big data and analytics. Compounding these challenges, there remain inefficient legacy IT systems, workflows, and processes, along with budget and resource constraints." Orange adds, "Our LifeSphere platform codifies decades of R&D and compliance expertise, making it available to our customers. LifeSphere NavaX builds on our proven platform, allowing the Life Sciences industry access to digital innovations that are driving the world forward."

NavaX Technology Highlights

NavaX is scalable and customizable; allows PV and Regulatory teams to remain in control and set their own pace based on their objectives, goals, and timing. NavaX supercharges LifeSphere solutions, which seamlessly integrate with third-party systems to ensure a smooth transition to a more intelligent and automated future. NavaX is built and enhanced with continuous inputs from pharmaceutical and regulatory partners, with the highest standards within the establishment of robust governance frameworks and compliance standards.

Today, more than 500 global pharmaceutical and biotech companies (90% of the Top 10 pharma brands) leverage LifeSphere, ArisGlobal’s open R&D and compliance platform transforming the way Life Science companies develop breakthroughs and bring new patient treatments to market, faster. Current LifeSphere platform customers have achieved exceptional process efficiency gains and cost savings. By powering next-generation digital process innovation, NavaX will supercharge operational efficiency, drive even faster time to insights, and ensure greater compliance.

Learn more about LifeSphere NavaX, here.

About ArisGlobal
ArisGlobal is the creator of LifeSphere, a market leader in global patient treatment technology solutions that is transforming the way today’s most successful life sciences companies develop breakthroughs and bring new products to market. Headquartered in the United States, ArisGlobal has regional offices in Europe, India, Japan, and China. For more updates, follow ArisGlobal on LinkedIn and www.arisglobal.com.

Logo – https://mma.prnasia.com/media2/1510670/ArisGlobal_Logo.jpg?p=medium600

Source : Expediting R&D Digitization for Life Sciences, ArisGlobal Introduces LifeSphere® NavaX™ – The Next-Generation Cognitive Computing Engine

>

This content was prepared by our news partner, Cision PR Newswire. The opinions and the content published on this page are the author’s own and do not necessarily reflect the views of Siam News Network